key: cord-0762974-2hic4hyz authors: Collinson, Paul O title: Commentary on Gastrointestinal Symptoms Followed by Shock in a Febrile 7-Year-Old Child during the COVID-19 Pandemic date: 2020-11-22 journal: Clin Chem DOI: 10.1093/clinchem/hvaa291 sha: 16efbfc6ce92c1ed98a39c07587da9d5aa931a62 doc_id: 762974 cord_uid: 2hic4hyz nan Paul O. Collinson* High-sensitivity cardiac troponin (cTn) assays are currently the best tool to detect subtle myocardial injury. More sensitive than myocardial imaging, highsensitivity assays have been estimated to detect necrosis of 40 mg of myocardial tissue-the equivalent of detecting 1 sugar cube dropped into Loch Ness. In patients who are severely ill, increased cTn may occur because of myocardial infarction or ischemic or nonischemic myocardial injury. Increased cTn has been reported in adults with severe coronavirus disease 2019 (COVID-19) infection (1) . As might be expected, cTn concentrations in these patients predict in-hospital death and correlate strongly with cardiac comorbidities (1). Conversely, COVID-19 infection in children is seen as a relatively benign condition with few, if any, significant adverse consequences. In this case report, Allali and colleagues described an unusual presentation of COVID-19 commencing with gastrointestinal symptoms and rash and progressing to multisystem inflammatory syndrome resembling Kawasaki disease. They demonstrated that measurement of cTn using a high-sensitivity assay can be used to identify cardiac involvement and to monitor and guide treatment. The pathophysiology of COVID-19-associated myocardial injury is poorly understood. Notably, a multicenter cardiovascular pathology study did not demonstrate disrupted coronary artery plaque (2) . In this study, multifocal myocarditis was identified in only 3 of 21 cases; 18 cases showed widespread interstitial macrophage infiltration of the myocardium without clearly associated myocardial injury, and 16 cases had increased troponin concentrations. Although there was no significant difference between those with or without myocarditis, there was a trend toward higher cTn concentrations with documented myocarditis. However, the authors considered that the etiology of myocardial injury in COVID-19 patients is not predominantly a viral myocarditis; rather, it reflects other pathophysiology, particularly the inflammatory state. Increased concentrations of C-reactive protein are a multivariate predictor of myocardial injury in COVID-19 infection (1). Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 4 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; (c) final approval of the published article; and (d) agreement to be accountable for all aspects of the article thus ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved. Jane W. Newburger* Symptomatic coronavirus disease 2019 (COVID-19) is far less common in children than adults; only about 2% of COVID-19 cases reported to the CDC occur in persons aged <18 years. However, the comfort that children were relatively less affected by acute COVID-19 was shattered in spring 2020, when reports of a syndrome of severe inflammation and multiorgan involvement, with features of Kawasaki disease (KD) and toxic shock syndrome, first emerged from Bergamo, Italy; London; and New York City. There is intense controversy about whether the KD-like illness associated with COVID-19, termed multisystem inflammatory syndrome in children (MIS-C) by the CDC, constitutes a form of KD triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or has a different pathophysiology. Although MIS-C and KD can be difficult to distinguish on occasion, there are notable differences (1). KD occurs predominantly in young children, with 80% of affected individuals younger than 5 years of age, whereas the majority of children with MIS-C are school aged and adolescent. MIS-C is overrepresented in Black and Hispanic children, whereas the relative risk of KD is highest in Asian children. Gastrointestinal symptoms are more common in MIS-C. Patients with MIS-C have higher D-dimer, ferritin, and troponin levels compared with patients with KD but have lower platelet and absolute lymphocyte counts. Finally, patients with MIS-C are more likely to present with shock and depressed ventricular function. Recent data suggest that the pathogenesis of SARS-CoV-2 infection involves autoreactivity and an inflammatory innate immune response (2) . Future research on the immunobiology of MIS-C compared with KD and their responses to therapies are urgently needed, as are data on long-term cardiac and systemic organ outcomes in MIS-C and the biology underlying those sequelae. There is also a critical need for further clinical and translational research to construct clinical care pathways for evidence-based management. Nonstandard Abbreviations: COVID-19, coronavirus disease-2019; CRP, C-reactive protein; IVIG, intravenous immunoglobulins; KD, Kawasaki disease; KDSS, KD shock syndrome; MIS-C, multisystem inflammatory system in children; NT-proBNP, N-terminal pro-BNP; RT-PCR, reverse transcription polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 4 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; (c) final approval of the published article; and (d) agreement to be accountable for all aspects of the article thus ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association Recognition of a Kawasaki disease shock syndrome Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-gamma as biomarkers for early recognition Hyperinflammatory shock in children during COVID-19 pandemic An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study Kawasakilike multisystem inflammatory syndrome in children during the covid-19 pandemic Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort Newhams MM, Son MBF, et al Multisystem inflammatory syndrome in U.S. children and adolescents Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 Utility of color Doppler echocardiography combined with clinical markers in diagnosis and prediction of prognosis of coronary artery lesions in Kawasaki disease Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study Acknowledgments: The authors thank the patient and his parents. They also thank the staff from the units who were involved in the diagnosis and clinical care of the patient, especially the pediatric intensive care unit, as well as Prof. Martin Chalumeau, Prof. Christèle Gras-Leguen, Prof. Sylvain Renolleau, Prof. Marianne Leruez, Prof. Véronique Abadie, Dr. Melissa Taylor, Dr. Agathe Debray, and Dr. Yael Pinhas for their contribution during various stages of the patient management and manuscript preparation.Ethics: The authors have obtained written parental consent for publication.Research Funding: None declared. Expert Testimony: None declared. Patents: None declared.